A Phase 3, Randomized Double-Blind, Placebo-Controlled Multicenter Study to Evaluate Efficacy and Safety of Repeated Administration of NurOwn® (Autologous Mesenchymal Stem Cells Secreting Neurotrophic Factors) in Participants With ALS
Investigator(s):
Namita Goyal, M.D.;
Organization:
UCI
NCT Number:
Disease Name:
Amyotrophic Lateral Sclerosis (ALS)
Disease Category:
Trial Phases:
Phase 3
Trial Status:
Recruiting
Trial Contact:
Active trials at UCI: http://clinic.stemcell.uci.edu/search-clinical-trials.asp
Contact for all open studies at UCI:
(949) 824-3990
stemcell@uci.edu